Akanocure Pharmaceuticals, Inc.
Seybold is an expert with 20 years of experience in business strategy, strategic financial planning, strategic partnership, executive management, and leadership. He is currently the Chief Financial Officer of Gemini Data and of FOUNDER.org; an impact investor that builds and funds impactful companies by choosing innovative startups from top universities around the world and an investor in Akanocure. Previously, he held several positions in the finance sector and served as a board member for several institutions such as Financial Executives International, San Fransisco Chapter. Seybold holds a Bachelor's degree in Finance and International Management from The Wharton School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Akanocure Pharmaceuticals, Inc.
Akanocure is a drug development company with a focus on orphan and unmet needs in oncology.